Curran Terrie

The estimated Net Worth of Curran Terrie is at least $460,498.95 dollars as of 05/25/2022. Curran Terrie is the Director of Myovant Sciences Ltd. Curran Terrie owns over 0 shares of Myovant Sciences Ltd stock worth over $0.00. Curran Terrie is the President and Chief Executive of Phathom Pharmaceuticals Inc. Curran Terrie owns over 65,319 shares of Phathom Pharmaceuticals Inc stock worth over $460,498.95.

Curran Terrie mailing address: C/O MYOVANT SCIENCES INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018

Insider Roles

Name Transaction Date Position
Myovant Sciences Ltd 2016-11-15 director
Phathom Pharmaceuticals Inc 2019-10-24 director
Arcutis Biotherapeutics Inc 2020-11-02 director
EMBED
SAVE

Curran Terrie trading transactions

Ticker Company Current Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost Final Share Price Change Since Insider Trade (%) Filing Date Dividend Yield % PE Ratio Market Cap ($M)
PHAT
Phathom Pharmaceuticals Inc
$7.17
Curran Terrie
President and Chief Executive
2022-05-13 Buy
20,500
45.74%
$7.41
$151,905
65,319.10
-3.31%
2022-05-16
0
At Loss
275.46
MYOV
Myovant Sciences Ltd
$9.66
Curran Terrie
Director
2021-09-09 Sell
4,850
-100%
$25.58
$124,063
0
-62.24%
-
0
At Loss
922.82
MYOV
Myovant Sciences Ltd
$9.66
Curran Terrie
Director
2021-09-02 Sell
48,508
-100%
$25.02
$1,213,670
0
-61.39%
-
0
At Loss
922.82
PHAT
Phathom Pharmaceuticals Inc
$7.17
Curran Terrie
President and Chief Executive
2021-03-22 Sell
11,513
-100%
$43.32
$498,743
0
-83.46%
-
0
At Loss
275.46
DELISTED:CELG
Celgene Corp
$108.24
Curran Terrie
SEE REMARKS
2019-09-18 Sell
11,338
-78.63%
$98.27
$1,114,190
3,081
10.15%
-
0
At Loss
77,035.98
DELISTED:CELG
Celgene Corp
$108.24
Curran Terrie
See remarks
2017-09-25 Sell
1,727
-27.63%
$143.89
$248,498
4,524
-24.78%
-
0
At Loss
77,035.98
Total 6
  • 1

Curran Terrie personal network

Name Position Linked company